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Small interfering RNAIncreased autophagy/mitophagy is thought to contribute to cerebellar dysfunction in Purkinje cell degeneration
mice. Intriguingly, cerebellar Purkinje cells are highly vulnerable to hypoxia–ischemia (HI), related at least in
part to their high metabolic activity. Whether or not excessive or supraphysiologic autophagy plays a role in
Purkinje cell susceptibility to HI is unknown. Accordingly, we evaluated the role of autophagy in the cerebellum
after global ischemia produced by asphyxial cardiac arrest in postnatal day (PND) 16–18 rats, using siRNA-
targeted inhibition of Atg7, necessary for microtubule-associated protein light chain 3-II (LC3-II) and Atg12–
Atg5 complex formation. Two days before a 9 min asphyxial cardiac arrest or sham surgery, Atg7 or control
siRNAwas injected intracisternally to target the cerebellum. Treatmentwith Atg7 siRNA: 1) reducedAtg7protein
expression in the cerebellum by 56%; 2) prevented the typical ischemia-induced formation of LC3-II in the cere-
bellum 24 h after asphyxial cardiac arrest; 3) improved performance on the beam-balance apparatus on days 1–
5; and 4) increased calbindin-labeled Purkinje cell survival assessed on day 14. Improved Purkinje cell survival
was more consistent in female vs. male rats, and improved beam-balance performance was only seen in female
rats. Similar responses to Atg7 siRNA i.e. reduced autophagy and neurodegeneration vs. control siRNAwere seen
when exposing sex-segregated green ﬂuorescent protein-LC3 tagged mouse primary cortical neurons to oxygen
glucose deprivation in vitro. Thus, inhibition of autophagy after global ischemia in PND 16–18 rats leads to in-
creased survival of Purkinje cells and improved motor performance in a sex-dependent manner.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Accelerated cerebellar Purkinje cell degeneration is seen in mice
with mutations in one of now several identiﬁed pcd alleles, with the
Purkinje cell degenerationmouse the ﬁrst to be characterized [1]. These
pcdmice demonstrate cerebellar ataxia and gait disturbances beginning
around postnatal day (PND) 21 and lose N99% of Purkinje cells by PND
42 [1]. This profound Purkinje cell vulnerability has been reported to
be at least in part due to excessive autophagy [2]. Autophagy is an
intracellular degradation pathway that is involved in the homeostatic
turnover of aging proteins and organelles, including mitochondria.n Research, 3434 Fifth Avenue,Autophagic degradation of mitochondria—termed “mitophagy”, can be
triggered by externalization of cardiolipin [3] or severe membrane
depolarization [4]. Autophagy proceeds via a complex interplay of
autophagy-related genes (Atgs), with Atg7 representing a central player
in its induction [5], although an Atg5/7-independent pathway has been
reported [6]. Atg7 is an ubiquitin E1-like enzyme that controls the crit-
ical step of converting Atg8/microtubule-associated protein light chain
3-I (LC3-I) to LC3-II via covalent attachment of phosphatidylethanol-
amine [7,8] and for the formation of Atg12–Atg5 complexes [9]. In-
creased autophagy in the injured brain has been reported after
multiple insults, including traumatic brain injury and hypoxia–ischemia
(HI) [10–15]. However, the role of autophagy after HI has been contro-
versial, as attempts to elucidate its role after HI have been limited by the
lack of speciﬁc pharmacological inhibitors, the requirement for basal
autophagy in normal neurodevelopment complicating studies in
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(siRNA) in the brain when injected in vivo [16–19].
In addition to being prone to neurodegeneration via dysregulation of
autophagy [2], cerebellar Purkinje cells are exquisitely vulnerable to HI
[20,21], both perhaps related to the fact that Purkinje cells have one of
the highest metabolic rates of any class of neurons. Purkinje cell vul-
nerability to HI and proclivity toward autophagy-induced neurode-
generation, in combination with the cerebellum's proximity to the
intracisternal space, provided us with the opportunity to directly evalu-
ate the role of autophagy after global brain HI in vivo, using a siRNA
strategy. In the present study, we were able to effectively reduce both
Atg7 protein abundance and HI-induced autophagy in the cerebellum
using injection of Atg7 siRNA into the intracisternal space. We then
evaluated the role of autophagy after HI by determining the effect of
Atg7 knockdown in the cerebellum on Purkinje cell survival and
vestibulomotor performance in ourmodel of pediatric asphyxial cardiac
arrest [22,23]. Lastly, we veriﬁed the capacity for Atg7 knockdown to in-
hibit ischemia-induced autophagic neurodegeneration using sex-
segregated green ﬂuorescent protein (GFP)–LC3 tagged (GFP–LC3+/−)
mouse primary cortical neurons exposed to oxygen-glucose deprivation
(OGD) in vitro.2. Materials and methods
2.1. Asphyxial cardiac arrest
Studies were approved by the Institutional Animal Care and Use
Committee at the University of Pittsburgh. A total of 90 rats were used
for the in vivo studies reported here, with 72 rats used for siRNA treat-
ment studies.
An established model of pediatric asphyxial cardiac arrest was uti-
lized for this study using PND16–18 rat pups [22,23]. This developmen-
tal age was chosen because in the rat it is similar in terms of cerebral
metabolism and blood ﬂow, dendritic pruning, and synaptogenesis, to
children 1–4 years of age [24]. PND 16–18 Sprague–Dawley rats (35–
40 g) were anesthetized with 3% isoﬂurane/50% N2O/balance oxygen
in a Plexiglas chamber until unconscious. Rats were intubated with
an 18-gauge angiocatheter and mechanically ventilated with 1%
isoﬂurane/50% N2O/balance oxygen for surgery. Tidal volumes and ven-
tilatory rateswere adjusted tomaintain PaCO2 35 to 45mmHg. Femoral
arterial and venous catheters (PE10) were inserted via inguinal cut
down. Mean arterial blood pressure, heart rate, and temperature were
monitored continuously. Vecuronium (1mg/kg, intravenously)was ad-
ministered 10min before asphyxia. Isoﬂuorane/N2Owas discontinued
2 min before asphyxia to allow washout of anesthetic. 1 min before
asphyxia, the FiO2 was reduced to 0.21 to avoid hyperoxygenation.
The endotracheal tube was disconnected from the ventilator for
9 min to induce asphyxial cardiac arrest. Resuscitation consisted of
reconnecting the tracheal tube to the ventilator at a FiO2 of 1.0, intra-
venous administration of epinephrine 0.005 mg/kg and sodium
bicarbonate 1 mEq/kg, and rapid manual chest compression until
return of spontaneous circulation. Vascular catheters were removed,
rats were extubated, observed for 1 h, then returned to their
mothers. Shams underwent all procedures except asphyxia and
resuscitation.
To characterize neurodegeneration in the cerebellum in this
model a separate group of male rats were sacriﬁced at 24 or
72 h after asphyxial cardiac arrest with naïve rats serving as con-
trol, and processed for histological assessment of neurodegenera-
tion (n = 3/group) or electron microscopy (n = 3/group).
Hemotoxylin and eosin staining and Fluorojade labeling of
degenerating neurons were performed in parafﬁn sections, and
ultrastructural analysis was performed in 65 nm ultrathin sec-
tions of cerebellum by transmission electron microscopy as pre-
viously described [22,25].2.2. Intracisternal administration of siRNA
Intracisternal (i.c.) injection was performed using a modiﬁcation of
the technique described by Consiglio et al. [26] for application in rat
pups. Naïve postnatal day (PND) 14–16 Sprague–Dawley rats were
anesthetized with 3% isoﬂurane/50% N2O/balance oxygen in a Plexiglas
chamber until unconscious. The head was ﬂexed and using sterile tech-
nique a 27-gauge butterﬂy needle was inserted vertically and centrally
approximately 2-mm posterior to the intra-aural line. The i.c. space
was identiﬁed by the appearance of CSF in the tubing, and veriﬁed by as-
piration of ~25 μl of CSF (to accommodate injection). A total of 800 pmol
of Atg7 siRNA (5′-GCAUCAUCUUUGAAGUGAA-3′; Sigma, PDSIRNA) or
non-targeting control siRNA (Fischer, D-001206-13-20)were combined
with 25 μl of jetSI (Polyplus Transfection, 55-126), a commercial cation-
ic polymer transfection reagent, formulated with dioleoylphosphatidyl
ethanolamine (DOPE) (Sigma, P1223) for i.c. injection. Commercially
obtained control siRNA consisted of missense sequences which have
not been shown to have off-target effects. A syringe containing 25 μl
of siRNA containing solution was injected slowly over 1 min to prevent
leakage from the puncture site, then the needlewaswithdrawn. Inhaled
anesthetics were discontinued and animals were allowed to recover
with their mothers prior to randomization to asphyxial cardiac arrest
or sham surgery.
The dose and timing of i.c. siRNA injection was based on pilot exper-
iments in separate naïve rats. A volume of 25 μl of solution—artiﬁcial CSF
containing Evans blue dye, was the maximum tolerated by rats at this
age. Evans blue dye was distributed prominently within and around
the cerebellum 24 h after injection. In our hands, themaximum amount
of siRNA that can be added to 25 μl is 800 pmol. Subsequent experi-
ments in naïve rats (n = 3/treatment group) using doses of 250–
800 pmol of Atg7 siRNA injected 24–48 h prior to sacriﬁce, demonstrat-
ed that Atg7 knockdownwas optimizedwith 800 pmol siRNA 48 h after
i.c. injection (56%). After i.c. injection Atg7 knockdown was seen in the
cerebellum, but not the cortex or hippocampus using western blot
(data not shown). Accordingly, for the remainder of experiments
800 pmol siRNA was injected i.c. 48 h before asphyxia or sham surgery
and we focused on effects in the cerebellum.2.3. Western blot analysis
For determination of effective siRNA knockdown, western blot anal-
ysis was performed as previously described [25,27] on cerebellar sam-
ples from male naïve rats 48 h after siRNA injection, and in male rats
24 h after asphyxial cardiac arrest (72 h after Atg7 or control siRNA in-
jection). Brieﬂy, ratswere anesthetized and transcardially perfusedwith
ice-cold saline. Brains were removed and the cerebellum was isolated.
Samples were homogenized with lysis buffer (20 mM HEPES-KOH,
pH 7.4, 10 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA,
250 mM sucrose, 1 mM DTT, 1 mM PMSF, 2 mg/ml aprotinin). Lysates
were serially centrifuged to separate cellular proteins, with the P2 frac-
tion containing autophagosomes, mitochondria, and small organelles.
Samples were stored at−80 °C in 10% glycerol. Protein concentration
was determined using a Bradford-based protein assay. Proteins were
loaded into 15% acrylamide gels, separated electrophoretically, then
transferred to a polyvinyl diﬂuoride membrane. The membranes were
incubated in 1:1000 dilution of monoclonal antibody against Atg7
(Sigma, A2856) or LC3 (MBL International, M115-3) at room tempera-
ture for 1 h, washed in phosphate-buffered saline (PBS) containing
0.1% Tween 20, then incubated in the appropriate secondary anti-
body for 1 h. The membranes were then incubated in chemilumines-
cence reagents, and exposed to X-ray ﬁlm. After imaging membranes
were washed and re-incubated using an antibody against cyto-
chrome oxidase IV (COX IV) to serve as a loading control. Relative op-
tical densities (ROD) of Atg7, LC3-II, and COX IV were calculated for
each sample.
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To assess vestibulomotor function,male and female rats were evalu-
ated using the beam balance and inclined plane tests on days 1–5 after
asphyxial cardiac arrest or sham injury. For the beam balance test, rats
were placed on a suspended narrow wooden beam (1.5 cm wide) and
the latency that the rat remained on the beamwas recorded for a max-
imum of 60 s. The rat was considered to have passed the test once it
remained on the beam for 45 s. This criterionwas based on the duration
where 90% of uninjured rats at these ages (PND 17–23) successfully
pass the test.
The inclined plane test consisted of a ﬂat board at an initial angle of
45°. The anglewas increased by 5° increments to amaximumof 80°. The
rat was placed on the board, and the steepest angle that it can maintain
its position on the board for 10 s is recorded. The rat was considered to
have passed the test once it could maintain its position on the platform
at 75°. This criterionwas based on the anglewhere 90% of uninjured rats
at these ages (PND 17–23) successfully pass the test.
2.5. Histological assessment
After completion of functional testing the rats were allowed to sur-
vive for a total of 14 days after asphyxia or sham surgery before being
sacriﬁced for assessment of Purkinje neuron survival. Purkinje neurons
are vulnerable to global ischemia after asphyxial cardiac arrest in both
developing [22] and adult rats [21]. Purkinje neurons were distin-
guished using calbindin immunohistochemistry. The 14 day survival
time was chosen to reduce the possibility that siRNA treatment effects
after asphyxia were temporary; and was based on recommendations
for experimental models of cerebral ischemia [28]. Brieﬂy, rats were
anesthetized with 3% isoﬂuorane and transcardially perfused with hep-
arinized ice-cold saline, followed by 2% paraformaldehyde. Brains were
dissected and further post-ﬁxed overnight, then transferred to a 30% su-
crose solution until equilibration. Brains were frozen in liquid nitrogen,
and mounted on a freezing stage of a sliding microtome. Sagittal sec-
tions of the cerebellum at a thickness of 10 μmwere obtained at 0, 0.5,
and 1 mm from midline. For immunohistochemistry, PBS was used for
all rinses. Sections were treated with 3% hydrogen peroxide, washed,
then blocked with 3% goat serum. Sections were then incubated in
monoclonal anti-Calbindin-D-28K (Sigma-Aldrich, C9848) diluted in
1.5% serum at 1:10,000 overnight at 4 °C. Following washes in PBS, the
secondary biotinylated mouse anti-IgG (Vector, PK-4002) was applied
for 1 h at room temperature, then visualized using an avidin–biotin–
HRP complex (ABC, Vector, PK-4002) and diaminobenzidine tetrahydro-
chloride (DAB, Vector, SK-4100). Slides were rinsed, dehydrated in alco-
hols, cleared in xylenes, and coverslips were applied using Permount
(Fisher).
Calbindin-positive Purkinje neurons were visualized using a
Nikon eclipse 90i microscope with the Nikon DS-Ri1 camera. Photos
were captured with NIS-Elements AR 3.10 imaging software at a
magniﬁcation of 10×. Calbindin-positive Purkinje neurons were
quantiﬁed in each sagittal section using Image J and the ITCN
(Image-based Tool for Counting Nuclei) plugin for Image J developed
by The Center for Bio-Image Informatics at The University of Califor-
nia, Santa Barbara.
2.6. In vitro oxygen glucose deprivation in primary cortical neurons
Sex-segregated primary cortical neurons were obtained from ED
16–17 GFP–LC3+/− mice as described [29]. Atg7 siRNA knockdown
was achieved using mouse Atg7 (5′-GCAUCAUCUUUGAAGUGAA-3′;
Sigma) with pooled non-targeting control siRNA (5′-AUGAACGUGAAU
UGCUCAA-3′, 5′ UAA GGCUAUGAAGAGUAC-3′, 5′-AUGUAUUGGCCU
GUAUUAG-3′, 5′-UAGCGACUAAACACAUCAA-3′; Dharmacon) used as
control as described [29]. Primary neurons were transfected on DIV 4with 20 nmol Atg7 or control siRNA using Lipofectamine 2000
(Invitrogen). Experiments were performed 72 h after transfection.
For OGD, Neurobasal medium and B27 supplements (Gibco) were
removed from neurons on day in vitro (DIV) 10 and replaced with
custom-made medium lacking sodium pyruvate and L-aspartate, and
with a ﬁnal concentration of 0.5 mM D-glucose and 2 mM L-glutamine.
The glucose deprived cultures were placed into a pre-warmed
Billups-Rothenberg modular incubator chamber containing 50 ml
sterile distilled-deionized water at 37 °C. The chamber was ﬂushed
with 95% argon and 5% CO2 for 15 min and then sealed. The cham-
ber was then placed in an incubator at 37 °C for 2 h. Afterward cul-
tures were returned to the incubator containing 95% air and 5%
CO2.
Autophagy and neurodegeneration were assessed as previously
described [29]. In brief, autophagy was quantiﬁed by measuring for-
mation of GFP–LC3 enriched vesicles in neurons grown on glass-
bottomed 25 mm Petri dishes (MatTek Corp.). GFP–LC3 ﬂuorescence
was enhanced using an anti-GFP conjugated antibody (Invitrogen)
and visualized using an inverted Olympus Fluoview 1000 micro-
scope. Fluorescent intensity above threshold values was quantiﬁed
in 8 areas (3000 × 3000 pixels) per dish using 6 dishes per group,
with threshold values deﬁned as the mean ﬂuorescent intensity of
control GFP–LC3 neurons. Cell death was determined by measuring
lactate dehydrogenase (LDH) release and propidium iodide (PI)
uptake.
2.7. Statistical analysis
Data are expressed as mean ± standard deviation (SD). Physiologi-
cal variables were compared using repeated measures analysis of vari-
ance (ANOVA). Between group comparisons of western blot data were
made using analysis of variance (ANOVA) with Tukey's post-hoc test.
The effect of treatment on calbindin-labeled Purkinje cell survival at
multiple levels through the cerebellum was analyzed using two-factor
ANOVA. Functional outcome (beam balance and inclined plane testing)
data are expressed as time to passing the test with between group com-
parisons made using the Log rank test. Since there were no within-sex
differences in sham-treated Atg7 siRNA and control siRNA groups,
motor performance data were combined into one female sham group,
and one male sham group, for analysis. Differences between groups in
the in vitro experiments were determined by ANOVA with Tukey's
post-hoc test.
3. Results
3.1. Purkinje cell degeneration after asphyxial cardiac arrest in PND 17 Rats
We ﬁrst sought to delineate the extent of Purkinje cell degeneration
in this model of pediatric cardiac arrest. Fig. 1 shows Purkinje cells that
are hyper-eosinophilic, Fluorojade C stained, and electron dense consis-
tent with neurodegeneration. Some cerebellar granule cells were also
hyper-eosinophilic and electron dense, exhibiting chromatin clumping.
Calbindin immunostaining distinguished Purkinje cells from other cell
types, and was therefore used for quantiﬁcation. A robust reduction in
calbindin immunoreactivity was observed after asphyxial cardiac arrest
compared with sham injury.
3.2. Intracisternal injection of Atg7 siRNA inhibited autophagy in the
cerebellum
The effect of Atg7 knockdown on autophagy in the cerebellum after
asphyxial cardiac arrest was assessed by measuring the relative abun-
dance of LC3-II (Fig. 2). At 24 h after 9 min asphyxial cardiac arrest, in-
creased LC3-II abundance was seen in the cerebellum from male rats
treated with control siRNA vs. naïve rats (P b 0.05; n= 3/group). Treat-
ment with Atg7 siRNA prevented formation of LC3-II in cerebellum
Fig. 1. Purkinje neurodegeneration after asphyxial cardiac arrest in male PND 17 rats. A. Hematoxylin and eosin (H&E) staining in coronal sections from a naïve rat showing normal cer-
ebellar morphology of the Purkinje and granule cell layers. B. H&E staining in a rat 72 h after asphyxial cardiac arrest showing classic hyper-eosinophilic Purkinje cells indicative of neu-
rodegeneration. C. Fluorojade C staining in coronal sections from a naïve rat without evidence of Purkinje or granule cell degeneration.D. Fluorojade C staining in a rat 72 h after asphyxial
cardiac arrest showing Fluorojade-positive neurons indicative of neuronal degeneration in some Purkinje and granule cells. E–I.Ultrastructural evaluation of cerebellum in a rat 72 h after
asphyxial cardiac arrest showing hyperchromatic and shrunken Purkinje cells with microvacuoles representing end stage neuronal degeneration (E and F; bar = 2 μm) corresponding to
hyper-eosinophilic and Fluorojade-positive neurons at the lightmicroscopic level. In addition, dark and shrunkengranule neuronswere also occasionally observed (G; bar=2 μm). Higher
magniﬁcation also revealedmicrovacuoles with various degenerating organelles in Purkinje cells (H and I; bar= 500 nm). J and K. Mid-sagittal sections of calbindin-immunolabeled cer-
ebellum. Loss of calbindin-positive Purkinje cells is seen in a rat 14 d after asphyxial cardiac arrest (K) vs. a rat 14 d after sham surgery (J). PrF = primary ﬁssure.
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Atg7 siRNA also reduced Atg7 protein abundance vs. control siRNA after
asphyxial cardiac arrest (P b 0.05). Of note, Atg7 was increased in cere-
bellum from rats treated with control siRNA after asphyxial cardiac ar-
rest vs. naïve rats (P b 0.05). Accordingly, the effect of HI alone on
Atg7 abundance in brain independent of siRNA treatment may warrant
further study.
3.3. Intracisternal injection of Atg7 siRNA improved beam balance perfor-
mance after asphyxial cardiac arrest
For functional outcome studies a total of 63 rats were randomized to
receive i.c. injection of 800 pmol (25 μl) of Atg7 or control siRNA 48 h
before asphyxial cardiac arrest or sham surgery. Of these, 3 rats diedbefore completion of functional outcome testing (1 male after control
siRNA injection and asphyxia and 2 males after control siRNA injection
and sham surgery). These rats were replaced to balance the groups.
Thus, vestibulomotor function was assessed in 9 male and 9 female
rats per treatment group after asphyxial cardiac arrest and 6 male and
6 female rats per treatment group after sham surgery using the beam
balance and incline plane apparatuses on days 1–5. After asphyxial ar-
rest, female rats treated with Atg7 siRNA were able to satisfactorily
pass the beam balance test (Fig. 3) more quickly than female rats treat-
ed with control siRNA (P = 0.02). However, this treatment effect was
not seen in male rats (P = 0.96). There was no signiﬁcant difference
in performance on the inclined plane apparatus in rats treated with
Atg7 vs. control siRNA, norwere injury-effects detected. These data sug-
gest that inhibition of autophagy in the cerebellum after asphyxial
Fig. 2. Prevention of ischemia-induced autophagy in cerebellum using Atg7 siRNA. West-
ern blot analysis of LC3-I and LC3-II in cerebellum of naïve male rats and male rats 24 h
after asphyxial cardiac arrest. At 48 h before asphyxial arrest, rats were randomized to re-
ceive control or Atg7 siRNA via intracisternal injection. In rats treated with control siRNA,
relative LC3-II protein abundance adjusted for cytochrome oxidase IV (COX IV) as a load-
ing control increased after asphyxial cardiac arrest vs. naïve rats (*P b 0.05). Treatment
with Atg7 siRNA prevented an ischemia-induced increase in LC3-II:COX IV vs. control
siRNA. Consistent with Fig. 2, Atg7:COX IV ratios were also reduced in Atg7 vs. control
siRNA treated rats after asphyxia. Mean ± SD, n = 3/group, *P b 0.05 vs. naïve, †P b 0.05
vs. control siRNA, ANOVA with Tukey's post-hoc test.
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manner, favoring female rats.3.4. Intracisternal injection of Atg7 siRNA improved Purkinje cell survival
after asphyxial cardiac arrest
Fourteen days after asphyxial cardiac arrest Purkinje cell survival
was assessed using calbindin staining (1 male rat in each of the treat-
ment groups died between functional outcome testing and 14 d sacri-
ﬁce). Calbindin is a calcium binding protein with a strong afﬁnity for
Purkinje cells [30,31]. Mid-sagittal sections of calbindin immunolabeled
cerebellum in rats after asphyxial cardiac arrest or sham surgery are
shown in Fig. 1J and K. Total calbindin-positive Purkinje cells were
counted in sagittal sections obtained at 0.0, 0.5, and 1.0-mm frommidline. Atg7 siRNA treatment signiﬁcantly improved Purkinje cell sur-
vival after asphyxial cardiac arrest compared with control siRNA treat-
ment in female but not male rats (P = 0.002 vs. 0.125, respectively;
n=9 females and 8males/group; Fig. 4). Interestingly, greater numbers
of Purkinje cells were seen in shammale vs. female rats (P b 0.05; n=6/
sex), suggesting a sex-difference in cerebellar development and/or ulti-
mate Purkinje cell number at this age. A highly signiﬁcant beneﬁcial ef-
fect of Atg7 siRNA treatment after asphyxial cardiac arrest was also
demonstrated when Purkinje cell survival was expressed as percent
Purkinje cells per sex-matched sham (Fig. 4C; P = 0.003; n = 17/
group). Overall Purkinje cell survival adjusted for baseline differences
between female and male rats was 91.6 ± 15.5% in the Atg7 siRNA
group vs. 78.6 ± 21.8% in the control siRNA group (P = 0.05). For
consistency of presentation, higher magniﬁcation images from
calbindin immunolabeled sections encompassing the terminus of
the cerebellar primary ﬁssure from representative rats from each
group are shown in Fig. 4D. Of note, relative to other regions of
the cerebellum, more Purkinje cell loss was observed in the pri-
mary ﬁssure (Fig. 1J, K).
The differences in Purkinje neuron survival could not be explained
by group differences in physiological derangements early after
asphyxial cardiac arrest. Physiological variables for each group used to
assess outcome provided in Tables 1 and 2. Typical physiological chang-
es, particularly a reduction in blood pressure and transient acidosis,
were observed early after asphyxial cardiac arrest vs. baseline values
and these changes were similar among all female or male sex and treat-
ment groups.
3.5. Atg7 siRNA inhibits autophagy and reduces neuronal death after OGD
in vitro
An increase in GFP–LC3 enriched vesicles was observed in neurons
from both male (XY) and female (XX)mice at 24 h after OGD, with ear-
lier (2 h) and more prominent increases seen in XY vs. XX neurons
(Fig. 5; P b 0.05 vs. control). This increase in GFP–LC3 enriched vesicle
formation was inhibited by Atg7 siRNA (Fig. 5A and B; P b 0.05 vs. con-
trol siRNA), consistent with GFP values above threshold representing
autophagosomes after OGD. Consistentwith autophagy-induced neuro-
degeneration, Atg7 siRNA treatment reduced cell death at 2 and 24 h
after OGD vs. control siRNA in both XY and XX neurons as evidenced
by LDH release (Fig. 5D; P b 0.05) and PI uptake (Fig. 5E; P b 0.05).
Cell death after OGD was more prominent in XY vs. neurons identiﬁed
using both LDH release and PI uptake.
4. Discussion
We found that administration of Atg7 siRNA via intracisternal injec-
tion prevented the increase in LC3-II formation in cerebellum typically
observed after asphyxial cardiac arrest, consistent with inhibition of
injury-induced autophagy. This targeted inhibition resulted in im-
proved Purkinje cell survival and vestibulomotor function in a sex-
dependent fashion, with effects observed predominantly—or with less
variability—in female rats. These data suggest that inhibition of autoph-
agy is beneﬁcial in terms of Purkinje cell survival after HI as a conse-
quence of asphyxial cardiac arrest in the developing brain; and are
consistent with a heightened vulnerability of Purkinje cells to increased
and/or dysregulation of autophagy [2].
We were able to inhibit Atg7 in the cerebellum by delivering Atg7
siRNA using a cationic polymer transfecting reagent formulated with
dioleoylphosphatidylethanolamine, and administering the siRNA via
local delivery into the intracisternal space. This siRNA delivery system
has been shown by Hassani et al. to effectively down-regulate gene ex-
pression in neurons after intra-cerebroventricular injection into mice
pups [32]. In our study, a reduction in Atg7 relative protein abundance
by 56% (Fig. 2) effectively prevented induction of autophagy typically
produced in thismodel of cerebral HI (Fig. 3). This incomplete reduction
Fig. 3. Reduction in ischemia-inducedmotor dysfunction using Atg7 siRNA. A–C. Beam balance performance on days 1–5 after asphyxial cardiac arrest or sham surgery. Data are presented
as the time required to successfully pass the test (deﬁned as the duration where 90% of age-matched sham rats pass) inmale rats (A), female rats (B), andmale and female rats combined
(C). D–F. Inclined plane performance on days 1–5 after asphyxial cardiac arrest or sham surgery. Data are presented as the time required to successfully pass the test (deﬁned as the du-
rationwhere 90% of age-matched sham rats pass) inmale (D), female rats (E), andmale and female rats combined rats (F). For sham n=12/group, for asphyxial cardiac arrest n= 9/sex/
group, female and male rats combined for panels C and F, *P= 0.02 vs. control siRNA, Log rank test.
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induced autophagy may be therapeutically desirable, given the impor-
tance of basal Atg7 for neuronal health and homeostasis, including in
Purkinje cells [33,34]. Mice that lack Atg7 in the CNS develop growth re-
tardation, motor and behavioral deﬁcits, and die within 28 weeks of
birth [33]. Koike et al. subjected these mice to HI injury via left carotid
artery occlusion followed by exposure to low oxygen, and found that
neonatalmice deﬁcient in CNS Atg7 showed nearly complete protection
as assessed by caspase-3 activation and pyramidal neuron death in the
hippocampus 7 days after injury compared with wild-type mice [18].
Due to the basal effects of complete Atg7 deﬁciency, they were unable
to address the potential role of ischemia-induced autophagy in older
mice. Taken together, the work by Koike at al. and the present study
in older postnatal rats suggest that while long-term disruption of au-
tophagy is detrimental, short-term blunting of the ischemia-induced
autophagy response may prove beneﬁcial in the developing brain.
The use of siRNA to inhibit autophagy in the brain in vivo has been
reported in another model of cerebral ischemia in adult rats. Zheng
et al. [35] administered lentiviral vectors encoding Beclin 1 short hairpin
RNA (LV-shBeclin1) into the ipsilateral ventricle 7 days prior to tran-
sient middle cerebral artery occlusion. Administration of LV-shBeclin1
resulted in down-regulation of Beclin 1 after cerebral ischemia with de-
creased infarct volume, reduced histological injury in the ipsilateral cor-
tex and hippocampus, and lower neurological deﬁcit scores. They also
showed a reduction in apoptosis in immature neurons, with increased
neurogenesis. These data imply that inhibition of autophagy by RNA in-
terference of Beclin 1 improves histological and neurological outcome
after cerebral ischemia. Cross talk between autophagy and apoptosis is
present due to the interactions of Beclin 1with Bcl-2 and Bcl-xL, and fur-
thermore caspase mediated cleavage of Beclin 1 forms fragments that
inhibit autophagy and activate apoptosis [36–38]; thus complicating
analysis of the impact of Beclin 1 as a direct effect on apoptosis cannot
excluded. Nonetheless, these data are consistent with the present
study and the concept that preventing ischemia-induced increases inautophagy is beneﬁcial following brain injury. That said and given the
challenges in using siRNA in brain in vivo, we performed parallel knock-
down experiments in primary neurons after OGD in vitro. The ﬁndings
that Atg7 siRNA reduced autophagosome formation and neurodegener-
ation (Fig. 5) were consistent with the in vivo experiments.
Consistent with a previous study from our laboratory showing sex-
differences in autophagy under conditions of starvation in vitro [29],
sex-differences in response to Atg7 knockdown were seen in the cur-
rent study; although in apparent contrast. Female rats had a tighter re-
sponse to Atg7 siRNA treatment in terms of Purkinje cell survival (91.0
vs. 76.2% in Atg7 vs. control siRNA groups, respectively) compared with
male rats (92.3 vs. 81.8% in Atg7 vs. control siRNA groups, respectively)
after asphyxial cardiac arrest, although the statistical power for themale
groups was 0.2, indicating that with a larger sample size signiﬁcant dif-
ferences may have been detected in male rats as well. Female rats sub-
jected to asphyxial cardiac arrest also had improved beam balance
performance after treatment with Atg7 vs. control siRNA. A treatment
effect on motor testing was not seen in male rats. The observed beneﬁt
of Atg7 knockdown primarily in female rats contradicted our previous
in vitro study [29], and it was initially anticipated that the effects of
Atg7 knockdown would likewise be more robust in male vs. female rats
after cerebral ischemia. Interestingly, after OGDAtg7 knockdown reduced
autophagic neurodegeneration in neurons from both male and female
mice (Fig. 5), and like starvation, showed more prominent autophagy in
neurons frommales vs. females. It is possible that partial Atg7 knockdown
is simply less effective in vivo than in vitro, and thuswewere only able to
detect a treatment effect in female rats after asphyxial arrest given our
sample sizes. Alternatively, since mortality in rats receiving siRNA was
only seen in males (4 receiving non-targeting siRNA and 1 receiving
Atg7 siRNA), death in the more severely impacted rats may have biased
our results toward a lack of treatment effects in males.
We found that baseline (sham) numbers of Purkinje neurons were
greater in male compared with female rats on PND 30–32. Sex differ-
ences in the rat brain have been described by Yanai [39], who reported
Fig. 4. Prevention of ischemia-induced Purkinje neurodegeneration using Atg7 siRNA. Calbindin-immunolabeled Purkinje cell counts per sagittal sectionmeasured at 0.0, 0.5 and 1.0 mm
frommidline inmale (A) and female (B) rats 14 d after asphyxial cardiac arrest or sham surgery. Increased Purkinje cell survival after asphyxial cardiac arrest was seen in rats treatedwith
Atg7 siRNA vs. control siRNA, with the treatment effect appearing more robust in female rats vs. their male counterparts. To account for sex-differences in baseline (sham) Purkinje cell
numbers, data are also expressed as thepercentage of Purkinje cells per sex-matched sham (C).D. Representative calbindin-immunolabeled sections showing Purkinje cell survival inmale
and female rats treatedwith control or Atg7 siRNA using the cerebellar primaryﬁssure as a point of reference are shown.Mean±SD, for shamn=6/sex/group, for asphyxial cardiac arrest
n = 9 females and 8 males/group, female and male rats combined for panel C (n = 17/group), *P b 0.005 vs. control siRNA, two-factor ANOVA.
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Table 1
Physiological variables: female rats.
Group Weight (gm) T (°C) HR (bpm) MAP (mm Hg) pH PaCO2 (mm Hg) PaO2 (mm Hg)
Sham control siRNA 35.2 ± 1.2 37.3 ± 0.1 398 ± 10 62.5 ± 3.4 7.36 ± 0.01 36.3 ± 0.5 198.4 ± 14.8
Sham Atg7 siRNA 36.0 ± 1.3 37.4 ± 0.1 420 ± 9 60.8 ± 0.8 7.36 ± 0.01 36.0 ± 0.4 232.8 ± 10.0
Asphyxia control siRNA
Baseline 35.6 ± 1.3 37.3 ± 0.1 404 ± 4 60.0 ± 2.0 7.37 ± 0.01 36.0 ± 0.4 220.8 ± 4.3
10 min 37.1 ± 0.1 373 ± 4a 62.2 ± 1.9 7.30 ± 0.02a 38.9 ± 2.7 326.8 ± 18.1a
30 min 37.3 ± 0.1 403 ± 12 45.0 ± 1.7a 7.38 ± 0.02 36.0 ± 1.5 343.2 ± 19.1a
60 min 37.3 ± 0.1 404 ± 9 46.7 ± 1.2a 7.39 ± 0.01 37.5 ± 1.1 371.9 ± 12.0a
Asphyxia Atg7 siRNA
Baseline 35.9 ± 1.0 37.2 ± 0.1 418 ± 9 65.6 ± 1.9 7.36 ± 0.01 35.8 ± 0.9 216.9 ± 10.8
10 min 37.1 ± 0.0 378 ± 9a 66.1 ± 1.8 7.29 ± 0.01a 39.3 ± 1.4a 323.4 ± 17.2
30 min 37.3 ± 0.1 426 ± 10 49.4 ± 2.1a 7.38 ± 0.02 36.4 ± 1.3 345.1 ± 15.1a
60 min 37.2 ± 0.1 424 ± 9 48.9 ± 1.4a 7.39 ± 0.01 35.6 ± 0.9 371.4 ± 11.7a
Abbreviations: T, temperature; HR, heart rate; bpm, beats per minute; MAP, mean arterial pressure.
a P b 0.05 vs. baseline.
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all ages (1 to 60 days). Additionally, males had 7.2% more Purkinje cells
than females, with Long–Evans rats having 9.6% more Purkinje cells
than Wistar rats (P b 0.01) [39]. No study to our knowledge has com-
pared Purkinje cell counts in male and female Sprague–Dawley rats
(which were utilized in the present study) at this developmental
stage. In the present study, the sex-difference in Purkinje cell number
may represent differences in cerebellar development and/or ultimate
Purkinje cell number. This absolute difference in Purkinje cell number
may affect how male and female rats deal with Purkinje cell death after
asphyxial cardiac arrest, consequently impacting their vestibulomotor
function.
There are limitations in the present study. First, while inhibition of
Atg7 using siRNA allows for more speciﬁc inhibition of the autophagic
pathway than existing pharmacological agents, Atg7 has also been im-
plicated in roles outside of autophagy. A deﬁciency of Atg7 during met-
abolic stress has been shown to increase p53-dependent apoptosis [40],
although this mechanism certainly cannot account for the neuroprotec-
tion seen in the current contextwe did not directly examine for apopto-
sis in this study. Second, the effectiveness of Atg7 siRNA injected into
the intracisternal space in our hands was limited to protein knockdown
in the cerebellum, thus, the role of autophagy after HI in other brain re-
gions such as the hippocampus could not be determined. Nevertheless,
this approach allowed us to speciﬁcally target the cerebellum. Third,
complete genetic disruption of Atg7 is known to result in profound neu-
rodegeneration, including in Purkinje cells [33,34]. Despite this fact, par-
tial reductions in Atg7 protein appear to be neuroprotective after
asphyxial cardiac arrest. The mechanisms underlying this difference
may relate to the completeness and/or chronicity of the Atg7 deﬁciency.Table 2
Physiological variables: male rats.
Group Weight (g) T (°C) HR (bpm)
Sham control siRNA 32.2 ± 1.2 37.3 ± 0.1 417 ± 12
Sham Atg7 siRNA 32.3 ± 1.2 37.2 ± 0.1 408 ± 12
Asphyxia control siRNA
Baseline 37.3 ± 1.0 37.2 ± 0.1 408 ± 9
10 min 37.1 ± 0.1 389 ± 7
30 min 37.3 ± 0.0 410 ± 9
60 min 37.2 ± 0.1 423 ± 12
Asphyxia Atg7 siRNA
Baseline 34.2 ± 1.4 37.3 ± 0.0 398 ± 10
10 min 37.1 ± 0.0 389 ± 7
30 min 37.2 ± 0.1 411 ± 7
60 min 37.2 ± 0.0 396 ± 10
Abbreviations: T, temperature; HR, heart rate; bpm, beats per minute; MAP, mean arterial pres
a P b 0.05 vs. baseline.Differences in the molecular regulation of basal versus injury-induced
autophagy have been reported in cultured neurons [41,42], and neuro-
protection is generally associated with inhibition of injury-induced in-
creases, rather than basal levels, of autophagy markers.5. Conclusions
In conclusion, inhibition of autophagy induced by global ischemia
leads to improved beam balance performance and increased survival
of cerebellar Purkinje cells in a sex-sensitive manner. These data are
consistent with a detrimental role for increased autophagy in brain
after asphyxial cardiac arrest in the developing brain.Transparency document
The Transparency document associated with this article can be
found, in the version.Acknowledgments
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Fig. 5.Oxygen-glucose deprivation (OGD) produces sex-dependent autophagy in primary cortical neurons fromGFP–LC3+/−mice. TheGFP signal was enhanced immunohistochemically.
A. Identiﬁcation of GFP–LC3 enriched vesicles consistent with autophagosome formation at 2 and 24 h after OGD. B. Quantiﬁcation of GFP–LC3 ﬂuorescent intensity peaks over threshold
(ﬂuorescence in control cells) showing that Atg7 siRNA reduces OGD-induced autophagosome formation in XY- and XX-neurons (n = 6/group; *P b 0.05 vs. control siRNA, †P b 0.05 vs.
control; ANOVAwith Tukey's test). C. GFP immunohistochemistry showing neuronal loss and formation of GFP-enriched vesicles after OGD. D and E. Treatment with Atg7 siRNA reduced
LDH release and increased neuron survival detected by PI labeling at 2 and 24 h after OGD in both XY- and XX-neurons vs. control siRNA (LDH, n= 6/group; PI, n= 4/group; *P b 0.05 vs.
control siRNA, †P b 0.05 vs. control; ANOVA with Tukey's test).
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